Rehabilitation Glasses for the Treatment of Hemispatial Neglect

Hemispatial Neglect Clinical Trial

Official title:

Rehabilitation Glasses for the Treatment of Hemispatial Neglect

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02695927
• Other study ID #: 2009P000297
• Status: Completed
• Phase: Phase 1
• Start date: March 2009
• Est. completion date: March 26, 2018

Study information

• Verified date: May 2018
• Source: Beth Israel Deaconess Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project is designed to test a lightweight, portable, computerized pair of glasses that will help reduce some of the cognitive deficits seen in patients who have suffered damage to their right cerebral hemisphere.

Description:

Hemispatial neglect is the inability or failure to attend and respond to the left side of space. Patients suffering right cerebral hemispheric damage from stroke or traumatic brain injury frequently suffer neglect and will ignore all information located in the left side of space. Currently there is no effective rehabilitation technique to treat neglect and many of these patients have severe long-term disability. The goal of this project is to determine whether a prototypical pair of rehabilitation glasses can reduce the symptoms of hemispatial neglect.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 38
• Est. completion date: March 26, 2018
• Est. primary completion date: March 26, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 85 Years

Eligibility

Inclusion Criteria:

• Presence of hemispatial neglect as defined by Behavioral Inattention Test score of 129 or worse (maximum score 146).

Exclusion Criteria:

• Presence of aphasia at time of testing,

• Recent seizures

• Major psychiatric illness

• Prior unrelated neurological disease

Related Conditions & MeSH terms

• Hemispatial Neglect
• Perceptual Disorders

Intervention

Device:
• Computer rehabilitation glasses

Locations

Country	Name	City	State
United States	Beth Israel Deaconess Medical Center	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Chun Lim

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement of patient's hemispatial neglect scores	Behavioral Inattention Test	60 days